US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

24.78

-0.0400-0.16%

Volume:761.79K

Turnover:18.92M

Market Cap:1.37B

PE:-9.84

High:25.99

Open:25.14

Low:24.45

Close:24.82

52wk High:53.65

52wk Low:22.01

Shares:55.25M

Float Shares:37.25M

Volume Ratio:1.80

T/O Rate:2.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5172

EPS(LYR):-3.0510

ROE:-37.35%

ROA:-21.79%

PB:3.02

PE(LYR):-8.12

Loading ...

Overview Company News Filings

Press Release: Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

Maze Therapeutics CSBO Atul Dandekar disposes 7,500 shares for $190,299

Maze Therapeutics announces annual shareholder meeting

Wedbush Cuts Price Target on Maze Therapeutics to $48 From $58, Keeps Outperform Rating

MT Newswires Live

Maze Therapeutics prices $150 million equity offering

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway

BUZZ-Maze Therapeutics jumps on $150 mln share offering for kidney disease drugs

Maze Therapeutics publishes corporate presentation on genetics-driven kidney and metabolic disease pipeline

BRIEF-Maze Therapeutics Announces $150 Million Registered Offering

Maze Therapeutics prices $150 million follow-on stock offering at $23.5 per share

Maze Therapeutics Inc - Prices 5,540,000 Shares at $23.50 per Share

THOMSON REUTERS

Maze Therapeutics Is Maintained at Buy by Truist Securities

Maze Therapeutics price target lowered to $64 from $68 at Truist

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Immuneering (IMRX) and Maze Therapeutics, Inc. (MAZE)

Assessing Maze Therapeutics (MAZE) Valuation After Strong One Year Return And Recent Pullbacks

Simply Wall St.

Wall Street Analysts Are Bullish on Top Healthcare Picks

Maze Therapeutics President R&D, CMO Harold Bernstein disposes shares worth $0.4 million

Maze SVP Finance Amy Bachrodt disposes Maze Therapeutics shares worth $0.1 million

Calendar of U.S. Earnings Expected in the Week Ahead

Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $0.2 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/MAZE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":24.78,"timestamp":1789151725583,"preClose":24.82,"halted":0,"volume":761793,"delay":0,"changeRate":-0.0016116035455277658,"floatShares":37250300,"shares":55248700,"eps":-2.517242,"marketStatus":"Trading","change":-0.04,"latestTime":"09-11 14:35:26 EDT","open":25.14,"high":25.99,"low":24.45,"amount":18918247.760499,"amplitude":0.062047,"askPrice":24.78,"askSize":99,"bidPrice":24.72,"bidSize":304,"shortable":3,"etf":0,"ttmEps":-2.517242,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":24.82,"preHourTrading":{"tag":"盘前","latestPrice":24.35,"preClose":24.82,"latestTime":"04:00 EDT","volume":1,"amount":24.35,"timestamp":1789113607899,"change":-0.47,"changeRate":-0.018936,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.82,"preClose":24.82,"latestTime":"19:30 EDT","volume":11916,"amount":295755.75,"timestamp":1789083010555,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.798806,"impliedVol":0.6802,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":37250300,"roa":"-21.79%","roe":"-37.35%","lyrEps":-3.051003,"volumeRatio":1.798806,"shares":55248700,"dividePrice":0,"high":25.99,"amplitude":0.062047,"preClose":24.82,"low":24.45,"week52Low":22.01,"pbRate":"3.02","psRate":"68.45","week52High":53.65,"institutionHeld":0,"latestPrice":24.78,"committee":0.508685,"eps":-2.517242,"divideRate":0,"volume":761793,"delay":0,"ttmEps":-2.517242,"open":25.14,"prevYearClose":41.43,"prevWeekClose":26.21,"prevMonthClose":26.57,"prevQuarterClose":29.84,"fiveDayClose":25.87,"twentyDayClose":27.665,"sixtyDayClose":23.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MAZE","fiscalQuarterEnding":"2026/06","expectedEps":-0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2026-05-12","symbol":"MAZE","fiscalQuarterEnding":"2026/03","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2026-03-25","symbol":"MAZE","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-11-06","symbol":"MAZE","fiscalQuarterEnding":"2025/09","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-08-12","symbol":"MAZE","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1773806400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2026-09-10","current":-9.844107,"percent":0.550868,"low":-19.775245,"twenty":-14.401765,"median":-10.769509,"eighty":9.151214,"high":14.99285,"avg":-5.068851,"sd":10.983382,"marketCap":1365398549},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-25","current":6.456504,"twenty":7.783022,"median":9.224877,"eighty":9.897831,"marketCap":337229638},{"date":"2025-05-02","current":8.879789,"twenty":7.580103,"median":8.972089,"eighty":9.731387,"marketCap":463800243},{"date":"2025-05-09","current":8.40184,"twenty":7.63209,"median":8.956237,"eighty":9.655299,"marketCap":438836491},{"date":"2025-05-16","current":7.799992,"twenty":7.63958,"median":8.89283,"eighty":9.626766,"marketCap":405123785},{"date":"2025-05-23","current":8.575775,"twenty":7.65241,"median":8.850167,"eighty":9.590307,"marketCap":445417178},{"date":"2025-05-30","current":10.26226,"twenty":7.715941,"median":8.87535,"eighty":9.631522,"marketCap":533011510},{"date":"2025-06-06","current":11.248853,"twenty":7.782471,"median":8.89283,"eighty":9.769431,"marketCap":584254194},{"date":"2025-06-13","current":11.425934,"twenty":7.799992,"median":8.956237,"eighty":10.149874,"marketCap":593451599},{"date":"2025-06-20","current":9.494909,"twenty":7.805949,"median":9.034945,"eighty":10.238649,"marketCap":493156089},{"date":"2025-06-27","current":10.742908,"twenty":7.871903,"median":9.097801,"eighty":10.238649,"marketCap":557975894},{"date":"2025-07-03","current":9.697287,"twenty":7.967493,"median":9.217791,"eighty":10.255514,"marketCap":503667409},{"date":"2025-07-11","current":13.188311,"twenty":8.01948,"median":9.285161,"eighty":10.297295,"marketCap":684987676},{"date":"2025-07-18","current":14.385715,"twenty":8.08904,"median":9.384234,"eighty":10.584212,"marketCap":747179651},{"date":"2025-07-25","current":13.871337,"twenty":8.197097,"median":9.417731,"eighty":10.84241,"marketCap":720463380},{"date":"2025-08-01","current":12.437825,"twenty":8.267679,"median":9.479345,"eighty":11.289329,"marketCap":646008198},{"date":"2025-08-08","current":11.231989,"twenty":8.274387,"median":9.503122,"eighty":11.660356,"marketCap":583378251},{"date":"2025-08-15","current":-4.846264,"twenty":8.197097,"median":9.495197,"eighty":11.50014,"marketCap":585409301},{"date":"2025-08-22","current":-4.802702,"twenty":7.843394,"median":9.46183,"eighty":11.412442,"marketCap":580147195},{"date":"2025-08-29","current":-5.180239,"twenty":7.675693,"median":9.408012,"eighty":11.34667,"marketCap":625752114},{"date":"2025-09-05","current":-5.459761,"twenty":7.605258,"median":9.384234,"eighty":11.299448,"marketCap":659517295},{"date":"2025-09-12","current":-9.002797,"twenty":7.051844,"median":9.285161,"eighty":11.248853,"marketCap":1087501923},{"date":"2025-09-19","current":-8.523616,"twenty":6.791906,"median":9.217791,"eighty":11.231989,"marketCap":1029618756},{"date":"2025-09-26","current":-9.565472,"twenty":6.372653,"median":9.072896,"eighty":11.223556,"marketCap":1155470793},{"date":"2025-10-03","current":-9.619925,"twenty":-4.846264,"median":8.956237,"eighty":11.080205,"marketCap":1162048426},{"date":"2025-10-10","current":-10.440341,"twenty":-4.897086,"median":8.912645,"eighty":10.903124,"marketCap":1261151423},{"date":"2025-10-17","current":-10.327806,"twenty":-5.035032,"median":8.87091,"eighty":10.852529,"marketCap":1247557649},{"date":"2025-10-24","current":-10.854179,"twenty":-5.43435,"median":8.743704,"eighty":10.801935,"marketCap":1311141431},{"date":"2025-10-31","current":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"marketCap":1456726366},{"date":"2025-11-07","current":-10.301208,"twenty":-8.440123,"median":8.622163,"eighty":10.742908,"marketCap":1299301692},{"date":"2025-11-14","current":-12.147078,"twenty":-8.530877,"median":8.52824,"eighty":10.604819,"marketCap":1532123096},{"date":"2025-11-21","current":-13.570087,"twenty":-9.148004,"median":8.467465,"eighty":10.501783,"marketCap":1711608623},{"date":"2025-11-28","current":-14.401765,"twenty":-9.516102,"median":8.389744,"eighty":10.458575,"marketCap":1816509011},{"date":"2025-12-05","current":-16.252058,"twenty":-9.864597,"median":8.267679,"eighty":10.366822,"marketCap":2049888314},{"date":"2025-12-12","current":-15.096102,"twenty":-10.151143,"median":8.122944,"eighty":10.312226,"marketCap":1904086399},{"date":"2025-12-19","current":-15.496681,"twenty":-10.373183,"median":7.957431,"eighty":10.278273,"marketCap":1954611815},{"date":"2025-12-26","current":-16.053676,"twenty":-10.591356,"median":7.799992,"eighty":10.266129,"marketCap":2024866203},{"date":"2026-01-02","current":-15.805699,"twenty":-10.832398,"median":7.756189,"eighty":10.248768,"marketCap":1993588564},{"date":"2026-01-09","current":-14.859569,"twenty":-11.164921,"median":7.639287,"eighty":10.225157,"marketCap":1874252343},{"date":"2026-01-16","current":-15.187663,"twenty":-11.722514,"median":7.479482,"eighty":10.213352,"marketCap":1915635065},{"date":"2026-01-23","current":-17.625471,"twenty":-12.065201,"median":7.127309,"eighty":10.196366,"marketCap":2223118312},{"date":"2026-01-30","current":-17.167667,"twenty":-12.419472,"median":6.955415,"eighty":10.162555,"marketCap":2165374980},{"date":"2026-02-06","current":-16.767088,"twenty":-13.567798,"median":6.791906,"eighty":10.126096,"marketCap":2114849563},{"date":"2026-02-13","current":-17.945934,"twenty":-14.175152,"median":6.511006,"eighty":10.056348,"marketCap":2263538645},{"date":"2026-02-20","current":-17.182927,"twenty":-14.401765,"median":6.360075,"eighty":9.954897,"marketCap":2167299757},{"date":"2026-02-27","current":-17.48813,"twenty":-14.737488,"median":-4.831743,"eighty":9.883564,"marketCap":2205795312},{"date":"2026-03-06","current":-17.282118,"twenty":-15.149512,"median":-4.864415,"eighty":9.832206,"marketCap":2179810813},{"date":"2026-03-13","current":-19.775245,"twenty":-15.332634,"median":-4.897086,"eighty":9.697287,"marketCap":2494271379},{"date":"2026-03-20","current":-18.857728,"twenty":-15.469975,"median":-4.962429,"eighty":9.697287,"marketCap":2378544116},{"date":"2026-03-27","current":-12.021519,"twenty":-15.550091,"median":-5.100375,"eighty":9.693343,"marketCap":1576261545},{"date":"2026-04-02","current":-11.013091,"twenty":-15.507363,"median":-5.260102,"eighty":9.683007,"marketCap":1444036514},{"date":"2026-04-10","current":-10.569535,"twenty":-15.475316,"median":-5.486987,"eighty":9.652715,"marketCap":1385877385},{"date":"2026-04-17","current":-10.186635,"twenty":-15.415039,"median":-5.764695,"eighty":9.626766,"marketCap":1335671640},{"date":"2026-04-24","current":-10.959561,"twenty":-15.395201,"median":-7.129635,"eighty":9.621519,"marketCap":1437017594},{"date":"2026-05-01","current":-11.209856,"twenty":-15.384518,"median":-8.456458,"eighty":9.590184,"marketCap":1469836362},{"date":"2026-05-08","current":-10.741725,"twenty":-15.342553,"median":-8.527247,"eighty":9.573739,"marketCap":1408454934},{"date":"2026-05-15","current":-11.93693,"twenty":-15.289905,"median":-9.002797,"eighty":9.561199,"marketCap":1462775248},{"date":"2026-05-22","current":-11.629812,"twenty":-15.205975,"median":-9.258724,"eighty":9.520559,"marketCap":1425140470},{"date":"2026-05-29","current":-11.92338,"twenty":-15.178506,"median":-9.458383,"eighty":9.511048,"marketCap":1461114890},{"date":"2026-06-05","current":-11.471737,"twenty":-15.158668,"median":-9.619925,"eighty":9.501537,"marketCap":1405769629},{"date":"2026-06-12","current":-10.880085,"twenty":-15.117466,"median":-9.821399,"eighty":9.495024,"marketCap":1333267337},{"date":"2026-06-18","current":-11.218817,"twenty":-15.001489,"median":-9.973866,"eighty":9.488683,"marketCap":1374776283},{"date":"2026-06-26","current":-12.203399,"twenty":-14.845835,"median":-10.113627,"eighty":9.465333,"marketCap":1495428952},{"date":"2026-07-02","current":-13.463484,"twenty":-14.807685,"median":-10.175262,"eighty":9.440942,"marketCap":1649842230},{"date":"2026-07-10","current":-14.642273,"twenty":-14.807685,"median":-10.243922,"eighty":9.423562,"marketCap":1794293361},{"date":"2026-07-17","current":-12.268888,"twenty":-14.735962,"median":-10.345957,"eighty":9.406427,"marketCap":1503454015},{"date":"2026-07-24","current":-12.506,"twenty":-14.713835,"median":-10.387794,"eighty":9.396916,"marketCap":1532510277},{"date":"2026-07-31","current":-12.478902,"twenty":-14.649742,"median":-10.467027,"eighty":9.384234,"marketCap":1529189561},{"date":"2026-08-07","current":-12.88538,"twenty":-14.642273,"median":-10.571027,"eighty":9.336679,"marketCap":1579000296},{"date":"2026-08-14","current":-11.503614,"twenty":-14.638297,"median":-10.649147,"eighty":9.29705,"marketCap":1536767732},{"date":"2026-08-21","current":-12.029624,"twenty":-14.610658,"median":-10.685878,"eighty":9.273272,"marketCap":1607037430},{"date":"2026-08-28","current":-11.892404,"twenty":-14.448066,"median":-10.740929,"eighty":9.231962,"marketCap":1588706204},{"date":"2026-09-04","current":-10.75722,"twenty":-14.401765,"median":-10.762812,"eighty":9.217791,"marketCap":1437056976},{"date":"2026-09-10","current":-10.220814,"twenty":-14.401765,"median":-10.769509,"eighty":9.151214,"marketCap":1365398549}],"updateTime":1789151726054},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635242733","title":"Press Release: Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242733?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:01","pubTimestamp":1778616060,"startTime":"0","endTime":"0","summary":"Positive topline data from Phase 2 HORIZON trial of MZE829 in patients with broad AMKD provide proof-of-concept and support advancement into pivotal trial; additional HORIZON data expected in late 2026 or early 2027. Phase 2 proof-of-concept clinical trials evaluating MZE782 in PKU and CKD on track to initiate in 2026. Strong balance sheet with $528 million in cash, cash equivalents and marketable securities; inclusive of net proceeds from the $150 million registered offering and $20 million MZE001 milestone payment in April 2026; cash runway expected to extend into 2029. 30% reduction in uACR. In patients with severe focal segmental","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4585","BK4007","FSGS","03160","BK4555","MAZE","TM","BK4588","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632506647","title":"Maze Therapeutics CSBO Atul Dandekar disposes 7,500 shares for $190,299","url":"https://stock-news.laohu8.com/highlight/detail?id=2632506647","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632506647?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:19","pubTimestamp":1777666755,"startTime":"0","endTime":"0","summary":"Maze Therapeutics CSBO Atul Dandekar exercised stock options for 7,500 common shares at USD 10.42 on April 29, 2026.Directly held common shares totaled 10,503 following transactions.Stock options beneficially owned totaled 44,143 following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL2Nr98G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics CSBO Atul Dandekar disposes 7,500 shares for $190,299","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631395235","title":"Maze Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631395235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631395235?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:52","pubTimestamp":1777409555,"startTime":"0","endTime":"0","summary":"Maze Therapeutics scheduled 2026 annual stockholder meeting for June 8, 2026 via virtual meeting.Vote planned on election of two Class I directors: Jason Coloma, Neil Kumar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL8hBx3Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629786832","title":"Wedbush Cuts Price Target on Maze Therapeutics to $48 From $58, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629786832","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629786832?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:12","pubTimestamp":1776949953,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) has an average rating of buy and mean price target of $63.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076510","title":"Maze Therapeutics prices $150 million equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076510","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076510?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:44","pubTimestamp":1776894249,"startTime":"0","endTime":"0","summary":"The latest update is out from Maze Therapeutics, Inc. ( ($MAZE) ). On April 21, 2026, Maze Therapeutics, Inc. priced an underwritten registered off...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-prices-150-million-equity-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maze-therapeutics-prices-150-million-equity-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629211910","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway","url":"https://stock-news.laohu8.com/highlight/detail?id=2629211910","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629211910?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:01","pubTimestamp":1776880908,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, YeswayWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL6N4150PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TH","HL","TSLA","DHR","STX","T","TSLS","OTIS","BSX","MAZE","HLXX","TSLY","SPWR","IMST","BOED","GEV","MSTK","07766","MSTR","NVR","CERT","BBY","HLTC","NKTR","COIN","MSTP","INBX","ADBE","07799","DJT","DGX","3LMI.UK","RIOT","TFX","AMRX","MAS","TEL","TWLO","YSWY","CDE","PM","BA","KYTX","WAB","NWMX","NEM","CALX","HOOD","ISRG","BOEG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629265220","title":"BUZZ-Maze Therapeutics jumps on $150 mln share offering for kidney disease drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629265220","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629265220?lang=en_us&edition=fundamental","pubTime":"2026-04-23 00:25","pubTimestamp":1776875120,"startTime":"0","endTime":"0","summary":"BUZZ-Maze Therapeutics jumps on $150 mln share offering for kidney disease drugs** Maze Therapeutics' MAZE.O shares up 6% to $27.23 on Weds after biopharma raises $150 mln to advance development of it","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL6N415159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999001440.SGD","BK4585","TROW","BK4567","MNSH","MAZE","BK4207","BK4588","BK4135","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629096481","title":"Maze Therapeutics publishes corporate presentation on genetics-driven kidney and metabolic disease pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629096481","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629096481?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:27","pubTimestamp":1776832062,"startTime":"0","endTime":"0","summary":"Maze outlined a kidney- and metabolic-disease pipeline built around small-molecule precision medicines, led by APOL1 inhibitor MZE829 for APOL1-mediated kidney disease .Initial Phase 2 HORIZON data showed a 36% mean reduction in uACR across 12 evaluable AMKD patients at 12 weeks.Non-diabetic AMKD patients posted a 49% mean uACR reduction, including a 62% mean reduction in FSGS subset.Safety update showed no serious adverse events in 15 treated patients; treatment-related adverse events were mostly mild or moderate.Maze projected operating capital into 2029, with additional HORIZON data targeted for late 2026 or early 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to gener","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLc1SrQc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629309668","title":"BRIEF-Maze Therapeutics Announces $150 Million Registered Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2629309668","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629309668?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:11","pubTimestamp":1776831060,"startTime":"0","endTime":"0","summary":"BRIEF-Maze Therapeutics Announces $150 Million Registered OfferingApril 22 (Reuters) - Maze Therapeutics Inc MAZE.O:MAZE THERAPEUTICS ANNOUNCES $150 MILLION REGISTERED OFFERINGMAZE THERAPEUTICS INC - ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA8CDHDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629096502","title":"Maze Therapeutics prices $150 million follow-on stock offering at $23.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2629096502","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629096502?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:09","pubTimestamp":1776830999,"startTime":"0","endTime":"0","summary":"Maze Therapeutics priced an underwritten registered offering of 5,540,000 common shares at USD 23.5 per share.Offering also includes pre-funded warrants for up to 850,000 shares at USD 23.499 per warrant.Gross proceeds expected at about USD 150 million.Net proceeds earmarked for R&D programs including MZE829 and MZE782, with cash runway projected into 2029.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL2DcyZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BN0W2W23.USD","LU2095319765.USD","BK4585","BK4588","LU2210150020.SGD","SG9999014005.SGD","LU2210149790.SGD","LU0314104364.USD","MAZE","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","BK4007","BK4112","SG9999014039.USD","IE00BGHQF748.EUR","BK4207","SG9999014021.USD","MNSH","IE00BKPKM429.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629096503","title":"Maze Therapeutics Inc - Prices 5,540,000 Shares at $23.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2629096503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629096503?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:09","pubTimestamp":1776830984,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA8CDHDM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627444771","title":"Maze Therapeutics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2627444771","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627444771?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:03","pubTimestamp":1776175380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2026 10:03 ET (14:03 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627448455","title":"Maze Therapeutics price target lowered to $64 from $68 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2627448455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627448455?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:17","pubTimestamp":1776165468,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Maze Therapeutics (MAZE) to $64 from $68 and keeps a Buy rating on the shares. The firm has updated its o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-lowered-to-64-from-68-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-price-target-lowered-to-64-from-68-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627172274","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Immuneering (IMRX) and Maze Therapeutics, Inc. (MAZE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627172274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627172274?lang=en_us&edition=fundamental","pubTime":"2026-04-14 18:30","pubTimestamp":1776162617,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Immuneering (IMRX) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-immuneering-imrx-and-maze-therapeutics-inc-maze-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-immuneering-imrx-and-maze-therapeutics-inc-maze-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","BK4007","MAZE","BK4588","XLV","BK4585","HCSG","TVTX","BK4539","BK4137","BK4563","XBI","LU0029874061.USD","LU0128526141.USD","BK4139","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626182292","title":"Assessing Maze Therapeutics (MAZE) Valuation After Strong One Year Return And Recent Pullbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2626182292","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626182292?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:23","pubTimestamp":1775733831,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE), a clinical stage biopharma focused on kidney and metabolic diseases, has drawn investor attention after recent share price swings and a one-year total return figure that stands in sharp contrast to its recent negative short-term moves.\nSee our latest analysis for Maze Therapeutics.\nRecent trading has been choppy, with a 1 month share price return showing a 37.66% decline and a year to date share price return showing a 29.37% decline. However, the 1 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-strong-one","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-strong-one","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932021","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932021","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932021?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:20","pubTimestamp":1775560826,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viridian Therapeutics (VRDN), Maze Therapeutics, Inc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-93?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-93?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","BK4585","LU0128526141.USD","MAZE","VRDN","XBI","LU0029874061.USD","BLSG","BLSX","BK4139","BK4137","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624823126","title":"Maze Therapeutics President R&D, CMO Harold Bernstein disposes shares worth $0.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624823126","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624823126?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:12","pubTimestamp":1775160750,"startTime":"0","endTime":"0","summary":"Maze Therapeutics President, R&D and CMO Harold Bernstein sold 15,000 shares on April 1.Sale prices ranged from $29.24 to $31.07 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4cD845:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682398","title":"Maze SVP Finance Amy Bachrodt disposes Maze Therapeutics shares worth $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682398","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624682398?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:11","pubTimestamp":1775160684,"startTime":"0","endTime":"0","summary":"Maze Therapeutics SVP, Finance Amy Bachrodt reported sales of 2,500 shares on April 1, 2026.Disposals totaled 2,200 shares at $29.32 per share, weighted average.Additional 300 shares were sold at $30.34 per share, weighted average.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL8sVnMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze SVP Finance Amy Bachrodt disposes Maze Therapeutics shares worth $0.1 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624772555","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2624772555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624772555?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:00","pubTimestamp":1775124000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Aehr Test Sys                                   3Q      (.07)  4:05 PM. ·Delta Air Lines Inc.                             1Q       .62   6:30 AM. ·Simply Good Fds                                 2Q       .40   7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","LU1267930227.SGD","BK4568","BYRN","BK4195","BK4204","BK4547","LAKE","BK4008","LU0772969993.USD","BK4559","LU2108987350.USD","LU1481011911.USD","BK4155","BK4500","LU2552382215.SGD","BK4149","LU1718418525.SGD","IE00BFSS8Q28.SGD","BK4533","BK4109","LU1983260115.SGD","IE00B7KXQ091.USD","KRUS","LU2211817866.USD","LU0731783394.SGD","IE00BKVL7J92.USD","SG9999004303.SGD","LU2552382058.USD","BK4097","NNOX","IE00B775H168.HKD","BK4023","BK4585","PSMT","LFCR","LU1069347547.HKD","APOG","LU0757428866.USD","LU0731783048.USD","LU2355687059.USD","NEOG","AYI","IE0004445015.USD","LU0128525689.USD","BK4187","AEHR","RPM","LU0170899867.USD","IE00BJJMRY28.SGD","MAZE","LU0070302665.USD","BK4007","IE00BN29S564.USD","RGP","LU1366192091.USD","SG9999011175.SGD","BK4209","LU0742537680.HKD","BK4121","BK4202","BK4196","BK4082","BK4152","BK4086","BK4169","DAL","BK4108","IE00BZ1G4Q59.USD","BK4588","LU1430594728.SGD","PXED","SLP","LEVI","LU1481011671.HKD","APLD","BK4116","LU0138981039.USD","SG9999003800.SGD","IE0031619046.USD","IE00BJJMRX11.SGD","LU0289960550.SGD","IE00BFMHRM44.USD","BB","LU2552382132.HKD","LU0310800965.SGD","BK4198","LU0054578231.USD","LU1035773651.USD","BK4211","BK4123","APLZ","BK4147","LU1235295455.SGD","LU1599440770.SGD","IE0005OL40V9.USD","LU0354030511.USD","BK4212","BK4096","PGR","BK4609","BK4563","LU0354030438.USD","LNN","WAFD","LU2087625088.SGD","BK4504","IE00BFSS7M15.SGD","APLX","IE00B66KJ199.SGD","ANGO","IE00B4JS1V06.HKD","LU0052756011.USD","LU1815336091.USD","LU0208291251.USD","LU0320765489.SGD","LU0203345920.USD","LU0353189680.USD","BK4608","LU0175139822.USD","IE00B7SZL793.SGD","SMPL","SGXZ23171101.USD","BK4107","LU0203347892.USD","LU1509826696.USD","STZ","BK4167","IE0004445239.USD","GBX","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624415549","title":"Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $0.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624415549","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624415549?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:13","pubTimestamp":1775074397,"startTime":"0","endTime":"0","summary":"Maze Therapeutics CSBO Atul Dandekar sold 7,500 shares on March 30, 2026 at USD 10.42.He also sold 6,710 shares at USD 29.26.An additional 790 shares were sold at USD 30.02.Directly owned stake fell to 10,503 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6Wpgm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maze Therapeutics CSBO Atul Dandekar disposes of common shares worth $0.2 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}